The Androgen Receptor Directly Targets the Cellular Fas/FasL-associated Death Domain Protein-like Inhibitory Protein Gene to Promote the Androgen-independent Growth of Prostate Cancer Cells

Overview

Journal Mol Endocrinol

Specialties Endocrinology
Molecular Biology

Date 2005 Feb 26

PMID 15731171

Citations 30

Authors

Shen Gao

Peng Lee

Hua Wang

William Gerald

Michael Adler

Liying Zhang

Yun-fang Wang

Zhengxin Wang

Affiliations

Soon will be listed here.

Abstract

Androgens provide survival signals to prostate epithelial cells, and androgen ablation induces apoptosis in the prostate gland. However, the molecular mechanisms of actions of the androgen-signaling pathway in these processes are not fully understood. Here, we report that androgens induced expression of the cellular Fas/FasL-associated death domain protein-like inhibitory protein (c-FLIP) gene, which is a potent inhibitor of Fas/FasL-mediated apoptosis. The androgen receptor was recruited to the promoter of the c-FLIP gene in the presence of androgens. We found that c-FLIP promoter contained multiple functional androgen response elements. In addition, we show that c-FLIP overexpression accelerated progression to androgen independence by inhibiting apoptosis in LNCaP prostate tumors implanted in nude mice. Our results suggest that the androgen receptor affects survival and apoptosis of prostate cells through regulation of the c-FLIP gene in response to androgens.

Citing Articles

TNF Signaling Is Required for Castration-Induced Vascular Damage Preceding Prostate Cancer Regression.

Krolewski J, Singh S, Sha K, Jaiswal N, Turowski S, Pan C Cancers (Basel). 2022; 14(24).

PMID: 36551505 PMC: 9775958. DOI: 10.3390/cancers14246020.

Integrating Pharmacogenomics Data-Driven Computational Drug Prediction with Single-Cell RNAseq to Demonstrate the Efficacy of a NAMPT Inhibitor against Aggressive, Taxane-Resistant, and Stem-like Cells in Lethal Prostate Cancer.

Mazumder S, Mitra Ghosh T, Mukherjee U, Chakravarti S, Amiri F, Waliagha R Cancers (Basel). 2022; 14(23).

PMID: 36497496 PMC: 9738762. DOI: 10.3390/cancers14236009.

Signaling Pathways That Control Apoptosis in Prostate Cancer.

Ali A, Kulik G Cancers (Basel). 2021; 13(5).

PMID: 33668112 PMC: 7956765. DOI: 10.3390/cancers13050937.

PVT1 signals an androgen-dependent transcriptional repression program in prostate cancer cells and a set of the repressed genes predicts high-risk tumors.

Videira A, Beckedorff F, daSilva L, Verjovski-Almeida S Cell Commun Signal. 2021; 19(1):5.

PMID: 33430890 PMC: 7798249. DOI: 10.1186/s12964-020-00691-x.

The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review.

Vickman R, Franco O, Moline D, Vander Griend D, Thumbikat P, Hayward S Asian J Urol. 2020; 7(3):191-202.

PMID: 32742923 PMC: 7385520. DOI: 10.1016/j.ajur.2019.10.003.

References

Orlando V, Paro R . Mapping Polycomb-repressed domains in the bithorax complex using in vivo formaldehyde cross-linked chromatin. Cell. 1993; 75(6):1187-98. DOI: 10.1016/0092-8674(93)90328-n. View

Jain A, Lam A, Vivanco I, Carey M, Reiter R . Identification of an androgen-dependent enhancer within the prostate stem cell antigen gene. Mol Endocrinol. 2002; 16(10):2323-37. DOI: 10.1210/me.2002-0004. View

Li P, Yu X, Ge K, Melamed J, Roeder R, Wang Z . Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer. Am J Pathol. 2002; 161(4):1467-74. PMC: 1867282. DOI: 10.1016/S0002-9440(10)64422-7. View

Porkka K, Visakorpi T . Molecular mechanisms of prostate cancer. Eur Urol. 2004; 45(6):683-91. DOI: 10.1016/j.eururo.2004.01.012. View

Wen Y, Hu M, Makino K, Spohn B, Bartholomeusz G, Yan D . HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway. Cancer Res. 2001; 60(24):6841-5. View

Xie X, Zhao X, Liu Y, Young C, Tindall D, Slawin K . Robust prostate-specific expression for targeted gene therapy based on the human kallikrein 2 promoter. Hum Gene Ther. 2001; 12(5):549-61. DOI: 10.1089/104303401300042483. View

Brinkmann A, Blok L, de Ruiter P, Doesburg P, Steketee K, Berrevoets C . Mechanisms of androgen receptor activation and function. J Steroid Biochem Mol Biol. 1999; 69(1-6):307-13. DOI: 10.1016/s0960-0760(99)00049-7. View

Kelly M, Hoel B, Voelkel-Johnson C . Doxorubicin pretreatment sensitizes prostate cancer cell lines to TRAIL induced apoptosis which correlates with the loss of c-FLIP expression. Cancer Biol Ther. 2002; 1(5):520-7. DOI: 10.4161/cbt.1.5.169. View

Santos A, Huang H, Tindall D . The androgen receptor: a potential target for therapy of prostate cancer. Steroids. 2004; 69(2):79-85. DOI: 10.1016/j.steroids.2003.10.005. View

10.

Hietakangas V, Poukkula M, Heiskanen K, Karvinen J, Sistonen L, Eriksson J . Erythroid differentiation sensitizes K562 leukemia cells to TRAIL-induced apoptosis by downregulation of c-FLIP. Mol Cell Biol. 2003; 23(4):1278-91. PMC: 141136. DOI: 10.1128/MCB.23.4.1278-1291.2003. View

11.

Bruckheimer E, Brisbay S, Johnson D, Gingrich J, Greenberg N, McDonnell T . Bcl-2 accelerates multistep prostate carcinogenesis in vivo. Oncogene. 2000; 19(46):5251-8. DOI: 10.1038/sj.onc.1203881. View

12.

Gelmann E . Molecular biology of the androgen receptor. J Clin Oncol. 2002; 20(13):3001-15. DOI: 10.1200/JCO.2002.10.018. View

13.

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

14.

Ge K, Guermah M, Yuan C, Ito M, Wallberg A, Spiegelman B . Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis. Nature. 2002; 417(6888):563-7. DOI: 10.1038/417563a. View

15.

Tilley W, Wilson C, Marcelli M, McPhaul M . Androgen receptor gene expression in human prostate carcinoma cell lines. Cancer Res. 1990; 50(17):5382-6. View

16.

Denmeade S, Lin X, Isaacs J . Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer. Prostate. 1996; 28(4):251-65. DOI: 10.1002/(SICI)1097-0045(199604)28:4<251::AID-PROS6>3.0.CO;2-G. View

17.

Partin A, Catalona W, Finlay J, Darte C, Tindall D, Young C . Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis. Urology. 1999; 54(5):839-45. DOI: 10.1016/s0090-4295(99)00270-8. View

18.

Chang D, Xing Z, Pan Y, Algeciras-Schimnich A, Barnhart B, Yaish-Ohad S . c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J. 2002; 21(14):3704-14. PMC: 125398. DOI: 10.1093/emboj/cdf356. View

19.

Latulippe E, Satagopan J, Smith A, Scher H, Scardino P, Reuter V . Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res. 2002; 62(15):4499-506. View

20.

Rees S, Coote J, Stables J, Goodson S, Harris S, Lee M . Bicistronic vector for the creation of stable mammalian cell lines that predisposes all antibiotic-resistant cells to express recombinant protein. Biotechniques. 1996; 20(1):102-4, 106, 108-10. DOI: 10.2144/96201st05. View